GAD1 and type 2 diabetes mellitus: Just as expressed in patients with T1DM, LADA patients test positive for glutamic acid decarboxylase (GAD) autoantibodies [102], but unlike patients with T1DM, it has been shown that LADA patients have worse long-term glycemic control compared to T2DM patients [103].